Tuberculosis (TB) is a devastating infectious disease caused by Mycobacterium tuberculosis that results in more than 8 million new cases and 1.4 million deaths every year. The efficacy of currently available anti-TB drugs has been compromised by the emergence of multidrug-resistant and extensively drug-resistant strains, therefore, there is an urgent need to develop novel therapeutic strategies against TB. In M. tuberculosis, three paralogous protein secretion systems - ESX-1, ESX-3 and ESX-5 - secrete PE-PPE dimers during defined stages of the infection process. PE and PPE proteins represent two large families of highly polymorphic proteins that are especially abundant in pathogenic mycobacteria. PE/PPE proteins are either cell wall associated or secreted into the extracellular milieu. These protein families are targets for vaccine development and diagnostic reagents. Multiple PE/PPE proteins play a role in in virulence, immune evasion and persistence in host. An outstanding question in the field is what the mechanisms of PE/PPE secretion and assembly in the cell wall of mycobacteria. This proposal is designed to help answer this important biological question by using a range of genetic, biochemical and structural approaches, including X-ray crystallography and mass-spectrometry. This study is significant because the protein secretion systems of M. tuberculosis, the ESX system in particular, are attractive targets for drug development. The results of our study will significantly advance our understanding of mycobacterial pathogenesis, and will provide structural knowledge that will guide the development of novel therapeutic targets and the design of a better vaccine against TB.

Public Health Relevance

The proposed studies are expected to uncover the architecture and mechanism of the ESX secretion system, a pathway essential for virulence and involved in the transport of multiple proteins to the cell surface or extracellular milieu in human pathogen M. tuberculosis. The generated data will provide a framework for developing novel therapeutics and improved vaccines against tuberculosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI119022-02
Application #
9114484
Study Section
Bacterial Pathogenesis Study Section (BACP)
Program Officer
Kraigsley, Alison
Project Start
2015-07-25
Project End
2019-12-31
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
2
Fiscal Year
2016
Total Cost
$376,250
Indirect Cost
$126,250
Name
University of Kentucky
Department
Biochemistry
Type
Schools of Medicine
DUNS #
939017877
City
Lexington
State
KY
Country
United States
Zip Code
40506
Tuukkanen, Anne T; Freire, Diana; Chan, Sum et al. (2018) Structural Variability of EspG Chaperones from Mycobacterial ESX-1, ESX-3, and ESX-5 Type VII Secretion Systems. J Mol Biol :
van Winden, Vincent J C; Ummels, Roy; Piersma, Sander R et al. (2016) Mycosins Are Required for the Stabilization of the ESX-1 and ESX-5 Type VII Secretion Membrane Complexes. MBio 7:
Wagner, Jonathan M; Chan, Sum; Evans, Timothy J et al. (2016) Structures of EccB1 and EccD1 from the core complex of the mycobacterial ESX-1 type VII secretion system. BMC Struct Biol 16:5